Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Radiopharm Theranostics Limited ( (AU:RAD) ) has shared an announcement.
Radiopharm Theranostics Limited announced a proposed issue of 415,706,190 ordinary fully paid securities, with the issue date set for October 24, 2025. This strategic move is likely aimed at raising capital to support the company’s ongoing projects and enhance its market position in the theranostics sector, potentially impacting stakeholders by increasing the company’s financial resources and operational capabilities.
The most recent analyst rating on (AU:RAD) stock is a Buy with a A$0.05 price target. To see the full list of analyst forecasts on Radiopharm Theranostics Limited stock, see the AU:RAD Stock Forecast page.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the healthcare industry, focusing on the development and commercialization of radiopharmaceutical products for diagnostic and therapeutic purposes. The company is involved in the emerging field of theranostics, which combines therapy and diagnostics to improve patient outcomes.
Average Trading Volume: 4,552,171
Technical Sentiment Signal: Buy
Current Market Cap: A$87.5M
For a thorough assessment of RAD stock, go to TipRanks’ Stock Analysis page.